PM

Popatlal Mukanchand Kathariya

Active Director Director DIN 00281395
DIN 00281395 First appointment Dec 2002 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Dec 2002
Shareholding value •••• Premium profile

About Popatlal Mukanchand Kathariya

Data last updated:

Popatlal Mukanchand Kathariya is a Director at Krebs Biochemicals And Industries Limited (since 2025) and Director at Sam Tax And Finance Services Private Limited (since 2002). The companies operate in Life Sciences, Business Outsourcing and Pharma. The largest current company by reported revenue is Krebs Biochemicals And Industries Limited at ₹44.02 Cr (FY 2025). Earlier, Popatlal Mukanchand Kathariya was a Director at Avik Pharmaceutical Limited (2014–2024) and Director at Ravi Kumar Distilleries Limited (2010–2024) and 2 more.

DIN 00281395
Primary Designation Director
Industry Life Sciences
First Appointment 24 Dec 2002
Oldest Company Age 38 yrs
Largest company Krebs Biochemicals And Industries Limited · ₹44.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Feb 20251991₹44.02 Cr (FY 2025)Active
Director24 Dec 20021987Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avik Pharmaceutical Limited U99999MH1979PLC021711
Director17 Sep 20141979₹103 Cr (FY 2025)Active
Ravi Kumar Distilleries Limited L51909PY1993PLC008493
Director03 Nov 20101993₹77.90 Cr (FY 2025)Active
Makers Laboratories Ltd L24230MH1984PLC033389
Director13 Feb 20191984₹133 Cr (FY 2025)Active
Fm Trading & Venture Private Limited U74999MH1985PTC036780
Director14 Sep 20051985Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sam Tax And Finance Services Private Limited
Krebs Biochemicals And Industries Limited
Avik Pharmaceutical Limited
Ravi Kumar Distilleries Limited
Premium access

Shareholding and investment profile for Popatlal Mukanchand Kathariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Popatlal Mukanchand Kathariya

Popatlal Mukanchand Kathariya currently holds 2 directorships: Krebs Biochemicals And Industries Limited (Director, since 04 Feb 2025, revenue ₹44.02 Cr (FY 2025)); Sam Tax And Finance Services Private Limited (Director, since 24 Dec 2002).

Popatlal Mukanchand Kathariya was first appointed on 24 Dec 2002 as Director at Sam Tax And Finance Services Private Limited. The most recent appointment on record is 04 Feb 2025 at Krebs Biochemicals And Industries Limited.

Popatlal Mukanchand Kathariya held 4 earlier board appointments: Avik Pharmaceutical Limited (Director, 17 Sep 2014 to 17 Sep 2024); Ravi Kumar Distilleries Limited (Director, 03 Nov 2010 to 23 Sep 2024); Makers Laboratories Ltd (Director, 13 Feb 2019 to 24 Sep 2020); Fm Trading & Venture Private Limited (Director, 14 Sep 2005 to 03 Oct 2009).

The current boards of Popatlal Mukanchand Kathariya's companies include Avinash Ravi (Krebs Biochemicals And Industries Limited), Dipti Chinubhai Shah (Krebs Biochemicals And Industries Limited), Manish Kumar Jain (Krebs Biochemicals And Industries Limited), Manish Kumar Jain (Krebs Biochemicals And Industries Limited), Pabitrakumar Kalipada Bhattacharyya (Krebs Biochemicals And Industries Limited), Rakesh Ravindra Kalbate (Krebs Biochemicals And Industries Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available